Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Publikation: Bidrag til tidsskrift › Leder › Forskning
Standard
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? / Ashina, Messoud; Martelletti, Paolo.
I: The Journal of Headache and Pain, Bind 19, Nr. 1, 33, 2018.Publikation: Bidrag til tidsskrift › Leder › Forskning
Harvard
Ashina, M & Martelletti, P 2018, 'Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?', The Journal of Headache and Pain, bind 19, nr. 1, 33. https://doi.org/10.1186/s10194-018-0860-4
APA
Ashina, M., & Martelletti, P. (2018). Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? The Journal of Headache and Pain, 19(1), [33]. https://doi.org/10.1186/s10194-018-0860-4
Vancouver
Ashina M, Martelletti P. Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? The Journal of Headache and Pain. 2018;19(1). 33. https://doi.org/10.1186/s10194-018-0860-4
Author
Bibtex
@article{46ba0f142ea9417fad24d3be916a671f,
title = "Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?",
author = "Messoud Ashina and Paolo Martelletti",
year = "2018",
doi = "10.1186/s10194-018-0860-4",
language = "English",
volume = "19",
journal = "Journal of Headache and Pain",
issn = "1129-2369",
publisher = "Springer",
number = "1",
}
RIS
TY - JOUR
T1 - Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
AU - Ashina, Messoud
AU - Martelletti, Paolo
PY - 2018
Y1 - 2018
U2 - 10.1186/s10194-018-0860-4
DO - 10.1186/s10194-018-0860-4
M3 - Editorial
VL - 19
JO - Journal of Headache and Pain
JF - Journal of Headache and Pain
SN - 1129-2369
IS - 1
M1 - 33
ER -
ID: 216870151